» Articles » PMID: 18597624

Age-dependent Demise of GNAS-mutated Skeletal Stem Cells and "normalization" of Fibrous Dysplasia of Bone

Overview
Date 2008 Jul 4
PMID 18597624
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

We studied the role of somatic mosaicism in fibrous dysplasia of bone (FD) within the context of skeletal ("mesenchymal") stem cells by assessing the frequency of mutated colony forming unit-fibroblasts (CFU-Fs) from FD lesions, and in some cases, from unaffected sites, in a series of patients. There was a tight inverse correlation between the percentage mutant CFU-F versus age, suggesting demise of mutant stem cells caused by exuberant apoptosis noted in samples from young patients. In older patients, either partially or completely normal bone/marrow histology was observed. On in vivo transplantation, FD ossicles were generated only by cell strains in which mutant CFU-Fs were identified. Strains that lacked mutant CFU-F (but were mutation positive) failed to regenerate an FD ossicle. These data indicate that GNAS mutations are only pathogenic when in clonogenic skeletal stem cells. From these data, we have evolved the novel concept of "normalization" of FD. As a lesion ages, mutant stem cells fail to self-renew, and their progeny are consumed by apoptosis, whereas residual normal stem cells survive, self-renew, and enable formation of a normal structure. This suggests that activating GNAS mutations disrupt a pathway that is required for skeletal stem cell self-renewal.

Citing Articles

Clival fibrous dysplasia in which short interval disease progression posed a diagnostic challenge in a skeletally mature patient: a case report.

Tinnut S, Pham N, Nayak J, Fernandez-Miranda J, Vogel H, Fischbein N J Med Case Rep. 2025; 19(1):83.

PMID: 40022171 PMC: 11871712. DOI: 10.1186/s13256-025-05104-6.


A narrative review of the literature on the pediatric orthopedic management of fibrous dysplasia.

Paris E, De Marco G, Vazquez O, Steiger C, Boudabbous S, Dayer R Front Pediatr. 2025; 12:1502262.

PMID: 39981406 PMC: 11841395. DOI: 10.3389/fped.2024.1502262.


The Use of Bone Biomarkers, Imaging Tools, and Genetic Tests in the Diagnosis of Rare Bone Disorders.

Alsarraf F, Ali D, Brandi M Calcif Tissue Int. 2025; 116(1):32.

PMID: 39841287 DOI: 10.1007/s00223-024-01323-z.


[Fibrous dysplasia].

Waltermann A, Westhoff B Orthopadie (Heidelb). 2024; 53(10):805-816.

PMID: 39235640 DOI: 10.1007/s00132-024-04548-w.


The prevalence, diagnostic accuracy and genotype-phenotype correlation of mutations in fibrous dysplasia: a meta-analysis.

Zhang A, Zhang J, Xue J, Wu Z, Xu Z, Sun L Front Genet. 2024; 15:1377716.

PMID: 39135681 PMC: 11317392. DOI: 10.3389/fgene.2024.1377716.


References
1.
Riminucci M, Fisher L, Shenker A, Spiegel A, Bianco P, Robey P . Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol. 1997; 151(6):1587-600. PMC: 1858361. View

2.
Krebsbach P, Kuznetsov S, Satomura K, Emmons R, Rowe D, Robey P . Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation. 1997; 63(8):1059-69. DOI: 10.1097/00007890-199704270-00003. View

3.
Riminucci M, Collins M, Fedarko N, Cherman N, Corsi A, White K . FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003; 112(5):683-92. PMC: 182207. DOI: 10.1172/JCI18399. View

4.
Bianco P, Robey P . An animal model of fibrous dysplasia. Mol Med Today. 1999; 5(7):322-3. DOI: 10.1016/s1357-4310(99)01485-9. View

5.
Alman B, Greel D, WOLFE H . Activating mutations of Gs protein in monostotic fibrous lesions of bone. J Orthop Res. 1996; 14(2):311-5. DOI: 10.1002/jor.1100140221. View